These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32958515)

  • 1. Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease.
    Lloyd K; Papoutsopoulou S; Smith E; Stegmaier P; Bergey F; Morris L; Kittner M; England H; Spiller D; White MHR; Duckworth CA; Campbell BJ; Poroikov V; Martins Dos Santos VAP; Kel A; Muller W; Pritchard DM; Probert C; Burkitt MD;
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32958515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
    Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway.
    Yao L; Chen X; Shen M; Zhao Y; Cao Q
    Int Immunopharmacol; 2023 Jan; 114():109532. PubMed ID: 36508925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.
    Huang Y; Zhang Y; Wan T; Mei Y; Wang Z; Xue J; Luo Y; Li M; Fang S; Pan H; Wang Q; Fang J
    Cell Biol Toxicol; 2021 Feb; 37(1):113-128. PubMed ID: 33130971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways.
    Almarzooqi S; Venkataraman B; Raj V; Alkuwaiti SAA; Das KM; Collin PD; Adrian TE; Subramanya SB
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
    Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
    Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM52 aggravated inflammation and pyroptosis in dextran sulfate sodium-induced inflammatory bowel disease through activation of the TLR4/NF-κBs pathway.
    Ma JP; Yao CZ; Jia ZQ; Wang AM; Miao XX; Gao XX; Su LP
    Allergol Immunopathol (Madr); 2023; 51(1):159-167. PubMed ID: 36617836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice.
    Yuan SN; Wang MX; Han JL; Feng CY; Wang M; Wang M; Sun JY; Li NY; Simal-Gandara J; Liu C
    Phytomedicine; 2023 Apr; 112():154702. PubMed ID: 36764096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
    J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.
    Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J
    Front Immunol; 2020; 11():592084. PubMed ID: 33240279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
    Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT2B activates macrophages via NF-κB signaling pathway in inflammatory bowel disease.
    Lan L; Huang C; Liu D; Cheng Y; Tang R; Gu J; Geng L; Cheng Y; Gong S
    FASEB J; 2024 Mar; 38(6):e23551. PubMed ID: 38489235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
    Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling.
    Chen X; Liu G; Yuan Y; Wu G; Wang S; Yuan L
    Cell Death Dis; 2019 Dec; 10(12):906. PubMed ID: 31787755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling.
    Dou W; Zhang J; Sun A; Zhang E; Ding L; Mukherjee S; Wei X; Chou G; Wang ZT; Mani S
    Br J Nutr; 2013 Aug; 110(4):599-608. PubMed ID: 23506745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokine C1q/Tumor Necrosis Factor- Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation Via Sirtuin 1/NF-κB Signaling.
    Yu H; Zhang Z; Li G; Feng Y; Xian L; Bakhsh F; Xu D; Xu C; Vong T; Wu B; Selaru FM; Wan F; Donowitz M; Wong GW
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):1000-1015. PubMed ID: 36592863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-κB pathway.
    Kang EA; Soh H; Park S; Lee HJ; Im JP; Kim JS
    Int Immunopharmacol; 2020 Sep; 86():106695. PubMed ID: 32570035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice.
    Han YM; Koh J; Kim JH; Lee J; Im JP; Kim JS
    Gut Liver; 2021 Jan; 15(1):100-108. PubMed ID: 32390406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
    Chun J; Lee C; Hwang SW; Im JP; Kim JS
    Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.